home All News open_in_new Full Article

Tyrimas atskleidė, kad „Ozempic“ ir panašūs vaistai mažina 42 susirgimų riziką

Remiantis išsamia poveikio 175 ligoms analize, teigiama, kad GLP-1 receptorių agonistais vadinami vaistai, kaip antai „Ozempic“ ir „Wegovy“, suteikia daugiau naudos nei nepageidaujamo poveikio, jei vartojami taip, kaip paskirta. Tačiau to paties negalima pasakyti apie tuos atvejus, kai šie vaistai vartojami kitais tikslais, skelbia „New Scientist“.


today 3 d. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics


ID: 1019452092
Add Watch Country

arrow_drop_down